GCSF (300 mcg/1 ml) subcutaneously on Day 14 onwards alternate days for two doses. Group B: Inj. GCSF (300 mcg/1 ml) instilled slowly into the uterine cavity using an intrauterine insemination (IUI) catheter under USG guidance. Endometrial thickness was assessed after 48 h. If endometrial...
Patients either received filgrastim (300 mcg, average of seven doses), pegylated filgrastim (6 mg, single dose), or no GCSF prophylaxis. In addition, 19 patients were asked to complete Functional Assessment of Cancer Therapy: General quality-of-life questionnaires. Results Overall, patients ...
Preliminary studies have indicated that AMD3100 given 10–11 hours before each apheresis along with standard doses of G-CSF mobilizes more CD34+ cells per kilogram than does G-CSF alone. A Phase II study of this combination in patients with NHL and myeloma is und...
Patients were treatedwith four weekly doses of 375mg/mof rituximab as a singletherapeutic agent at days 1, 8, 15 and 22. CHOP chemotherapyhad been administered at days 50, 72, 94 and 116 and was followedby GCSF starting at day 3 of each chemotherapy cycle. In caseof disease progression...
Methods, Results & Conclusion We describe a Phase 3 pivotal study to meet regulatory requirements as a confirmatory study in subjects with NORDA, defined as 1) experiencing ongoing angina despite use of maximally tolerated doses of anti-anginal medications, 2) limited by angina after at least 3...
Provides information on a study that compared two doses of recombinant human granulocyte-stimulating factor for stem cell mobilization in healthy donors for allogeneic stem cell transplantation. Details on the patients and methodologies used; Results and discussion.Kroger...